Laying Claim To DNA

Law360, New York (August 18, 2011, 2:53 PM EDT) -- On July 29, 2011, the Federal Circuit handed down the hotly anticipated decision in Association for Molecular Pathology v. USPTO, Fed. Cir., No. 2010-1406, July 29, 2011. In a 2-1 decision, the panel held that isolated DNA molecules are eligible for patent protection under 35 U.S.C. § 101.

The substantive dispute among the parties is whether claims to isolated DNA impermissibly encompass a product of nature. Myriad argued that isolated DNA is patent eligible because it is “a nonnaturally occurring composition of matter” with “a distinctive...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.